Microbiome modulators in the treatment of infectious diseases: insights from clinical trials

Shidong Wang, Chenjuan Wang, Linhua Shen, Mengjin Zhu, Jiannong Wu · 2024

Read Microbiome modulators in the treatment of infectious diseases: insights from clinical trials by Shidong Wang, Chenjuan Wang, Linhua Shen, Mengjin Zhu, Jiannong Wu (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11575062.txt.

Description

Shidong Wang and four colleagues present a 2024 research letter taking stock of a fashionable treatment idea: fighting infections by tuning the microbiome. Probiotics, prebiotics, fecal transplants, and engineered living medicines all aim to strengthen barriers, crowd out pathogens, or stir the immune system. The team searched a clinical trials database for this strategy in infectious disease.

They found eight hundred fifty-eight trials meeting their criteria as of September 2024. Trial counts climbed steeply after 2012 and peaked in 2021, and most trials had completed, including many late-phase ones, signaling real clinical momentum. The authors read the landscape as a field moving from curiosity to contenders, and they map where the trials concentrate.

Catalog record

CREATORShidong Wang, Chenjuan Wang, Linhua Shen, Mengjin Zhu, Jiannong Wu
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE7 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11575062

Browse the full library · About the Tower of Babel